Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cue Biopharma (CUE) Asset Utilization Ratio (2018 - 2025)

Cue Biopharma's Asset Utilization Ratio history spans 8 years, with the latest figure at 0.2 for Q3 2025.

  • For Q3 2025, Asset Utilization Ratio fell 10.29% year-over-year to 0.2; the TTM value through Sep 2025 reached 0.2, down 10.29%, while the annual FY2024 figure was 0.2, 175.82% up from the prior year.
  • Asset Utilization Ratio for Q3 2025 was 0.2 at Cue Biopharma, down from 0.26 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.29 in Q1 2025 and bottomed at 0.0 in Q1 2023.
  • The 5-year median for Asset Utilization Ratio is 0.12 (2024), against an average of 0.13.
  • The largest annual shift saw Asset Utilization Ratio plummeted 96.98% in 2023 before it skyrocketed 2333.89% in 2024.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.18 in 2021, then plummeted by 91.93% to 0.01 in 2022, then skyrocketed by 466.62% to 0.08 in 2023, then surged by 186.51% to 0.24 in 2024, then decreased by 18.65% to 0.2 in 2025.
  • Per Business Quant, the three most recent readings for CUE's Asset Utilization Ratio are 0.2 (Q3 2025), 0.26 (Q2 2025), and 0.29 (Q1 2025).